U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07594028) titled 'Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours' on May 11.
Brief Summary: This study aims to evaluate the safety, tolerability, PK characteristics, immunogenicity, and preliminary anti-tumor efficacy of SCTB41 in combination with SCTB39-1with or without standard therapy in adult patients with advanced malignant solid tumours. This study is an open label, multicentre, dose-escalation and dose-expansion Phase I/II clinical trial.
Study Start Date: May 30
Study Type: INTERVENTIONAL
Condition:
Advanced Malignant Solid Tumor
Intervention:
DRUG: SCTB41+SCTB39-1
SCTB41 plus SCTB39-1...